130 related articles for article (PubMed ID: 7684446)
1. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
[TBL] [Abstract][Full Text] [Related]
2. alpha N-acetyl-beta-endorphin-(1-31) disrupts the diminishing effect of mastoparan on opioid- and clonidine-evoked supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1995 May; 273(2):787-92. PubMed ID: 7752081
[TBL] [Abstract][Full Text] [Related]
3. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
4. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
5. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
[TBL] [Abstract][Full Text] [Related]
7. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
8. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
Porreca F; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI
J Pharmacol Exp Ther; 1992 Oct; 263(1):147-52. PubMed ID: 1328602
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
11. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
Xu JY; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain.
Garzon J; Juarros JL; Castro MA; Sanchez-Blazquez P
Mol Pharmacol; 1995 Apr; 47(4):738-44. PubMed ID: 7723734
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
15. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1994 Mar; 268(3):1107-13. PubMed ID: 7511163
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
[TBL] [Abstract][Full Text] [Related]
17. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of descending pain inhibitory pathways activated by beta-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice.
Roerig SC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1988 Dec; 247(3):1107-13. PubMed ID: 2974485
[TBL] [Abstract][Full Text] [Related]
19. Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats.
Tseng LF; Towell JF; Fujimoto JM
J Pharmacol Exp Ther; 1986 Apr; 237(1):65-74. PubMed ID: 2420969
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
Selley DE; Bidlack JM
J Pharmacol Exp Ther; 1992 Oct; 263(1):99-104. PubMed ID: 1328614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
